Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen-Reference-Cited by-同舟云学术

Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen

Published:2015-11 Issue:1 Volume:168 Page:105-110
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Frigerio Barbara,Benigni Fabio,Luison Elena,Seregni Ettore,Pascali Claudio,Fracasso Giulio,Morlino Sara,Valdagni Riccardo,Mezzanzanica Delia,Canevari Silvana,Figini Mariangela

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference24 articles.

1. Development trends for human monoclonal antibody therapeutics;Nelson;Nat. Rev. Drug Discov.,2010

2. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory;Arnold;Eur. J. Cancer,2015

3. Cancer survival in Europe 1999–2007 by country age: results of EUROCARE—5-a population-based study;De;Lancet Oncol.,2014

4. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy;Wright;Urology,1996

5. Expression of prostate-specific membrane antigen in normal, benign, malignant prostate tissue;Wright;Urol. Oncol.,1995

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer;International Journal of Molecular Sciences;2023-12-29

2. D2B-Functionalized Gold Nanoparticles: Promising Vehicles for Targeted Drug Delivery to Prostate Cancer;ACS Applied Bio Materials;2023-02-09

3. Human blood biocompatibility and immunogenicity of scFvD2B PEGylated gold nanoparticles;Nanotechnology;2022-05-11

4. Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review;Biomedicines;2021-12-10

5. D2B antibody and its scFvD2B fragment in nanomedicine: promising tools in the theranostics of prostate cancer;Advances in Natural Sciences: Nanoscience and Nanotechnology;2021-09-01